NantHealth (NASDAQ:NH) and CHURCHILL CAP C/SH (NYSE:CCC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Valuation and Earnings

This table compares NantHealth and CHURCHILL CAP C/SH’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NantHealth $89.46 million 0.88 -$192.15 million ($1.74) -0.41
CHURCHILL CAP C/SH N/A N/A $1.24 million N/A N/A

CHURCHILL CAP C/SH has lower revenue, but higher earnings than NantHealth.

Profitability

This table compares NantHealth and CHURCHILL CAP C/SH’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NantHealth -191.63% -10,113.15% -62.59%
CHURCHILL CAP C/SH N/A 2.88% 1.20%

Analyst Recommendations

This is a breakdown of current ratings for NantHealth and CHURCHILL CAP C/SH, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NantHealth 0 0 1 0 3.00
CHURCHILL CAP C/SH 0 1 2 0 2.67

NantHealth presently has a consensus target price of $1.00, indicating a potential upside of 41.04%. CHURCHILL CAP C/SH has a consensus target price of $18.50, indicating a potential upside of 17.68%. Given NantHealth’s stronger consensus rating and higher probable upside, equities analysts clearly believe NantHealth is more favorable than CHURCHILL CAP C/SH.

Insider & Institutional Ownership

3.3% of NantHealth shares are held by institutional investors. Comparatively, 25.9% of CHURCHILL CAP C/SH shares are held by institutional investors. 64.5% of NantHealth shares are held by insiders. Comparatively, 2.3% of CHURCHILL CAP C/SH shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

CHURCHILL CAP C/SH beats NantHealth on 6 of the 10 factors compared between the two stocks.

NantHealth Company Profile

NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, as well as whole transcriptome sequencing; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; Liquid GPS, a blood-based molecular test; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

CHURCHILL CAP C/SH Company Profile

Churchill Capital Corp, a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2018 and is based in New York, New York.

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.